VT
TAK icon

Vise Technologies’s Takeda Pharmaceutical TAK Stock Holding History

Vise Technologies’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
118,124
+21,807
+23% +$361K 0.02% 562
2026
Q1 		$1.5M Hold
96,317
– – 0.03% 452
2025
Q4 		$1.5M Buy
96,317
+16,817
+21% +$240K 0.03% 453
2025
Q3 		$1.16M Sell
79,500
-1,141
-1% -$16.9K 0.04% 391
2025
Q2 		$1.25M Buy
+80,641
New +$1.19M 0.05% 379
2024
Q4 		$459K Buy
34,635
+1,026
+3% +$14.1K 0.04% 464
2024
Q3 		$478K Buy
33,609
+9,387
+39% +$133K 0.06% 312
2024
Q2 		$313K Sell
24,222
-2,631
-10% -$34.8K 0.06% 302
2024
Q1 		$373K Buy
26,853
+1,830
+7% +$26.6K 0.07% 251
2023
Q4 		$357K Buy
25,023
+449
+2% +$6.37K 0.08% 236
2023
Q3 		$380K Sell
24,574
-1,303
-5% -$20.2K 0.09% 209
2023
Q2 		$407K Sell
25,877
-8,156
-24% -$134K 0.1% 202
2023
Q1 		$561K Buy
34,033
+3,674
+12% +$58.5K 0.15% 149
2022
Q4 		$474K Sell
30,359
-890
-3% -$12.4K 0.15% 156
2022
Q3 		$405K Buy
31,249
+10,390
+50% +$144K 0.15% 164
2022
Q2 		$293K Buy
20,859
+9,464
+83% +$135K 0.11% 202
2022
Q1 		$163K Buy
+11,395
New +$167K 0.06% 246

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vise Technologies's TAK Position: Q2 2026 in Review

Vise Technologies increased its Takeda Pharmaceutical (TAK) stake by 23% in Q2 2026, buying an estimated $361K and bringing the position to 118,124 shares worth $1.89M. The position accounts for 0.02% of the portfolio, ranked #562.

Vise Technologies first reported a position in TAK in Q1 2022 and has held it in 17 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Vise Technologies held 118,124 shares of Takeda Pharmaceutical worth $1.89M as of Q2 2026.
  • Vise Technologies bought 21,807 Takeda Pharmaceutical shares in Q2 2026, an estimated $361K.
  • Takeda Pharmaceutical made up 0.02% of Vise Technologies's portfolio in Q2 2026, its #562 holding.
  • Vise Technologies first reported a position in Takeda Pharmaceutical in Q1 2022 and has held it in 17 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.